摘要:
An organic light emitting device that includes an anode, a cathode, and an emissive layer that includes an organic compound selected from and at least one emissive dopant. The emissive dopant can be one of a variety of organometallic iridium complexes.
摘要:
Novel ligands for metal complex compounds that are useful as a phosphorescent emitter in organic light emitting devices that incorporate fluorinated side chains in the ligands are disclosed. Such metal complex has at least one substituent R selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof, wherein R is directly bonded to an aromatic ring, In the compound, C having an F attached thereto is separated by at least one carbon atom from the aromatic ring.
摘要:
Compounds comprising phosphorescent metal complexes comprising cyclometallated imidazo[1,2-f]phenanthridine and diimidazo[1,2-a:1′,2′-c]quinazoline ligands, or isoelectronic or benzannulated analogs thereof, are described. Organic light emitting diode devices comprising these compounds are also described.
摘要:
A compound comprising a ligand LA of Formula I: as well as, devices and formulations containing the compound of Formula 1 are disclosed. In the compounds, having a ligand La of Formula I: wherein R1 represents mono, or di- substitution, or no substitution; wherein R2 represents mono, di, tri, or tetra-substitution, or no substitution; wherein R is selected from hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof; wherein R1 and R2 are each independently selected from hydrogen, deuterium, alkyl, cycloalkyl, aryl, and combinations thereof; wherein any adjacent substituents of R2 are optionally joined to form a fused ring; wherein the ligand LA is coordinated to a metal M; and wherein the ligand LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate or hexadentate ligand.
摘要:
A compound comprising a first ligand LA of Formula I,
is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.
摘要:
A compound having the formula (LA)mIr(LB)3-m, where LA is
and LB is
is disclosed. In the formula (LA)mIr(LB)3-m, LA and LB are different; each of X1 to X5 is C—RF or nitrogen; X is selected from O, S, and Se; each R1, R2, RB, RD, and RF is hydrogen or a substituent; R3 is alkyl, cycloalkyl, or a combination thereof; and m is 1 or 2. OLEDs, consumer products, and formulations including the compound are also disclosed.
摘要:
A heteroleptic compound of formula Ir(LA)m(LB)n, where LA has a structure of Formula I, and LB has Formula II, is provided. In Formulae I and II, moieties A and D are independently a rings or polycyclic ring systems, one of moiety A and moiety D is coordinated to Ir by a 5-membered ring, and the other is coordinated to Ir by a 6-membered ring; each of X, X1 to X12 is C or N; Y is a linking atom; each RA, RB, RC, RD, and RE is hydrogen or a general substituent; and at least one RD or RE substituent comprises an electron-withdrawing group, or an aryl or heteroaryl substituted with an electron-withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.
摘要:
A compound comprising a ligand of LA of Formula I, is provided with variables as defined herein. Formulations, OLEDs, and consumer products including the compound are also disclosed.
摘要:
Provided is a compound including a first ligand LA of Formula I, In Formula I, moiety A is a monocyclic ring or a multicyclic fused ring system; one of X1, X2, and X3 is C and is connected to X4; one of X1, X2, and X3 is N and is coordinated to a metal M; and the remaining one of X1, X2, and X3 is CR or N; X4 is C or N; Y is a divalent linking group; each R, R′, RA, and RB is independently hydrogen or a General Substituent; each of K1 and K2 is independently direct bond, O, or S; and metal M is selected from the group consisting of Os, Ir, Pd, Pt, Cu, Ag, and Au. Formulations, OLEDs, and consumer products including the same are also provided.
摘要:
A compound including a first ligand LA of Formula I, is disclosed. In Formula I, ring B is a 5- or 6-membered ring; X1, X2, and X3 are each CRA or N; R is a 5- or 6-membered carbocyclic or heterocyclic ring, which can be further fused or substituted; and (1) when ring B is an unfused 6-membered ring, X1 and X2 are N, and X3 is C; and (2) when ring B is a fused 6-membered ring, ring B has the structure of Formula II, In this structure, the wavy line indicates the point of connection to ring A; Q1 to Q6 are each C or N; and, when proviso (2) applies, (I) at least one of X1, X2, and X3 is N; or (II) R is two or more fused or unfused 5- or 6-membered carbocyclic or heterocyclic rings, or (III) at least ring A or R is substituted with a partially or fully deuterated alkyl or partially or fully deuterated cycloalkyl group.